Profile data is unavailable for this security.
About the company
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
- Revenue in EUR (TTM)449.88m
- Net income in EUR17.67m
- Incorporated1967
- Employees3.23k
- LocationBoiron SA2 avenue de l ouest LyonnaisRONTALON 69510FranceFRA
- Phone+33 478456100
- Fax+33 478456291
- Websitehttp://www.boiron.fr/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innate Pharma SA | 34.62m | -77.37m | 366.77m | 212.00 | -- | 2.74 | -- | 10.59 | -0.98 | -0.98 | 0.4386 | 1.69 | 0.1155 | -- | 17.01 | 141,877.00 | -25.82 | -6.92 | -32.62 | -10.00 | 88.58 | 93.94 | -223.49 | -39.97 | -- | -27.05 | 0.3186 | -- | -18.59 | 25.68 | -208.22 | -- | 60.28 | -- |
| Cellectis SA | 61.96m | -112.87m | 380.74m | 340.00 | -- | 1.81 | -- | 6.14 | -2.56 | -2.56 | 1.42 | 4.62 | 0.1562 | -- | 31.99 | 182,241.70 | -31.55 | -22.99 | -38.71 | -28.53 | -- | -18.04 | -201.92 | -217.46 | 4.72 | -30.94 | 0.2852 | -- | 258.66 | 5.68 | 20.59 | -- | 62.49 | -- |
| Abivax SA | 0.00 | -38.66m | 425.65m | 29.00 | -- | -- | -- | -- | -2.48 | -2.48 | 0.00 | -0.3047 | 0.00 | -- | -- | 0.00 | -73.70 | -37.26 | -160.24 | -48.72 | -- | -- | -- | -- | 0.6267 | -17.82 | 1.16 | -- | -- | -- | -22.58 | -- | -2.61 | -- |
| Carbios SA | 832.00k | -8.30m | 428.94m | 39.00 | -- | 2.79 | -- | 515.55 | -0.8265 | -0.8265 | 0.0826 | 13.77 | 0.0085 | 2.30 | 1.72 | 26,838.71 | -8.44 | -9.65 | -8.81 | -10.37 | 89.06 | -- | -997.72 | -87.55 | 21.72 | -118.02 | 0.0351 | -- | -7.17 | 9.97 | -63.94 | -- | 39.04 | -- |
| Guerbet SA | 711.76m | 32.90m | 449.92m | 2.64k | 13.74 | 1.16 | 5.04 | 0.6321 | 2.60 | 2.60 | 56.14 | 30.75 | 0.7395 | 0.7914 | 5.70 | 270,116.50 | 3.42 | 3.54 | 4.40 | 5.05 | 75.96 | 75.98 | 4.62 | 4.54 | 1.26 | 4.32 | 0.4613 | 28.04 | -12.81 | 7.82 | -52.55 | -14.70 | 12.35 | 1.49 |
| AB Science SA | 1.59m | -10.90m | 574.49m | 96.00 | -- | -- | -- | 360.41 | -0.2253 | -0.2253 | 0.0331 | -0.2725 | 0.0624 | -0.0408 | 4.58 | 17,326.09 | -42.66 | -73.56 | -575.20 | -189.51 | 100.50 | 86.77 | -683.81 | -1,452.39 | 1.08 | -- | 163.58 | -- | 0.7638 | -7.07 | 30.82 | -- | -9.75 | -- |
| Boiron SA | 449.88m | 17.67m | 624.62m | 3.23k | 35.27 | 1.27 | 12.14 | 1.39 | 1.01 | 1.01 | 25.69 | 27.94 | 0.6031 | 1.38 | 5.98 | 134,533.50 | 2.37 | 7.32 | 3.07 | 9.21 | 74.67 | 78.19 | 3.93 | 9.64 | 2.02 | 78.56 | 0.0209 | 43.78 | -7.82 | -3.31 | -35.49 | -18.73 | -4.49 | -8.73 |
Data as of Dec 02 2021. Currency figures normalised to Boiron SA's reporting currency: Euro EUR
12.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Natixis Investment Managers International SAas of 31 Dec 2020 | 995.37k | 5.67% |
| Financi�re de l'�chiquier SAas of 31 Dec 2020 | 445.80k | 2.54% |
| Sycomore Asset Management SAas of 30 Sep 2021 | 199.93k | 1.14% |
| Norges Bank Investment Managementas of 31 Dec 2020 | 160.34k | 0.91% |
| BlackRock Fund Advisorsas of 04 Nov 2021 | 102.32k | 0.58% |
| Dimensional Fund Advisors LPas of 04 Nov 2021 | 93.81k | 0.54% |
| The Vanguard Group, Inc.as of 31 Oct 2021 | 78.58k | 0.45% |
| SMA Gestion SAas of 30 Jun 2020 | 75.56k | 0.43% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2021 | 64.42k | 0.37% |
| Fidecum AGas of 30 Jul 2021 | 23.50k | 0.13% |
More ▼
Data from 30 Jun 2020 - 30 Sep 2021Source: FactSet Research Systems Inc.
